Section 103 - Poisons and Therapeutic Goods Regulation 2008 - Possession of drugs of addiction at private health facilities and residential care facilities

103Possession of drugs of addiction at private health facilities and residential care facilities

Start here

Get a plain-English read of 103

Turn the raw legal text into a practical explanation grounded in Poisons and Therapeutic Goods Regulation 2008.

103 Possession of drugs of addiction at private health facilities and residential care facilities

(1) The following persons are authorised to have possession of ampoules of morphine sulphate in a quantity not exceeding 30 ampoules, each of 1 millilitre or less, at a concentration of 30 milligrams or less of morphine sulfate per millilitre—

(a) the director of nursing of a private health facility,

(b) the responsible person for a residential care facility,

(c) a registered nurse at a residential care facility, but for the purpose only of administering doses of such drugs to individual residents of the residential care facility.

(2) The director of nursing of a private health facility is authorised to have possession of no more than 5 ampoules, each of 2 millilitres or less, of pethidine hydrochloride, at a concentration of 50 milligrams or less of pethidine hydrochloride per millilitre.

(3) Order of Secretary—specified facilities The Secretary may, by order in writing, authorise the possession of a drug of addiction specified in subclause (1) or (2), in a quantity that exceeds the limit specified in subclause (1) or (2), by the following persons—

(a) in the case of morphine sulphate—

(i) the director of nursing of a specified private health facility, or

(ii) the responsible person for a specified residential care facility,

(b) in the case of pethidine hydrochloride—the director of nursing of a specified private health facility.

(4) Order of Secretary—specified classes of facilities The Secretary may, by order published in the Gazette, authorise the possession of a drug of addiction specified in subclause (1) or (2), in a quantity that exceeds the limit specified in subclause (1) or (2), by the following persons—

(a) in the case of morphine sulphate—

(i) the director of nursing of a specified class of private health facilities, or

(ii) the responsible person for a specified class of residential care facilities,

(b) in the case of pethidine hydrochloride—the director of nursing of a specified class of private health facilities.